Logo image of PHIA.AS

KONINKLIJKE PHILIPS NV (PHIA.AS) Stock Fundamental Analysis

Europe - AMS:PHIA - NL0000009538 - Common Stock

24.45 EUR
+0.19 (+0.78%)
Last: 10/20/2025, 7:00:00 PM
Fundamental Rating

3

PHIA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 59 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of PHIA have multiple concerns. PHIA is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

PHIA had positive earnings in the past year.
PHIA had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: PHIA reported negative net income in multiple years.
Of the past 5 years PHIA 4 years had a positive operating cash flow.
PHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFPHIA.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B

1.2 Ratios

The Return On Assets of PHIA (0.61%) is worse than 62.71% of its industry peers.
Looking at the Return On Equity, with a value of 1.56%, PHIA is doing worse than 62.71% of the companies in the same industry.
PHIA has a Return On Invested Capital (4.27%) which is in line with its industry peers.
Industry RankSector Rank
ROA 0.61%
ROE 1.56%
ROIC 4.27%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
PHIA.AS Yearly ROA, ROE, ROICPHIA.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

PHIA has a Profit Margin of 0.91%. This is in the lower half of the industry: PHIA underperforms 62.71% of its industry peers.
PHIA has a Operating Margin (6.11%) which is in line with its industry peers.
In the last couple of years the Operating Margin of PHIA has declined.
Looking at the Gross Margin, with a value of 43.85%, PHIA is doing worse than 71.19% of the companies in the same industry.
PHIA's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.11%
PM (TTM) 0.91%
GM 43.85%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
PHIA.AS Yearly Profit, Operating, Gross MarginsPHIA.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

2

2. Health

2.1 Basic Checks

PHIA has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
PHIA has less shares outstanding than it did 1 year ago.
PHIA has more shares outstanding than it did 5 years ago.
PHIA has a worse debt/assets ratio than last year.
PHIA.AS Yearly Shares OutstandingPHIA.AS Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M
PHIA.AS Yearly Total Debt VS Total AssetsPHIA.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

PHIA has an Altman-Z score of 1.94. This is not the best score and indicates that PHIA is in the grey zone with still only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.94, PHIA perfoms like the industry average, outperforming 40.68% of the companies in the same industry.
The Debt to FCF ratio of PHIA is 19.41, which is on the high side as it means it would take PHIA, 19.41 years of fcf income to pay off all of its debts.
PHIA has a Debt to FCF ratio of 19.41. This is comparable to the rest of the industry: PHIA outperforms 40.68% of its industry peers.
PHIA has a Debt/Equity ratio of 0.69. This is a neutral value indicating PHIA is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.69, PHIA is doing worse than 74.58% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 19.41
Altman-Z 1.94
ROIC/WACC0.65
WACC6.54%
PHIA.AS Yearly LT Debt VS Equity VS FCFPHIA.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

PHIA has a Current Ratio of 1.26. This is a normal value and indicates that PHIA is financially healthy and should not expect problems in meeting its short term obligations.
PHIA has a Current ratio of 1.26. This is in the lower half of the industry: PHIA underperforms 61.02% of its industry peers.
A Quick Ratio of 0.81 indicates that PHIA may have some problems paying its short term obligations.
PHIA's Quick ratio of 0.81 is on the low side compared to the rest of the industry. PHIA is outperformed by 66.10% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.81
PHIA.AS Yearly Current Assets VS Current LiabilitesPHIA.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B

4

3. Growth

3.1 Past

PHIA shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 11.17%, which is quite good.
PHIA shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -7.17% yearly.
PHIA shows a decrease in Revenue. In the last year, the revenue decreased by -1.53%.
PHIA shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.00% yearly.
EPS 1Y (TTM)11.17%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%21.91%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-2.12%

3.2 Future

PHIA is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 12.26% yearly.
Based on estimates for the next years, PHIA will show a small growth in Revenue. The Revenue will grow by 3.26% on average per year.
EPS Next Y0.42%
EPS Next 2Y5.48%
EPS Next 3Y7.81%
EPS Next 5Y12.26%
Revenue Next Year-1.83%
Revenue Next 2Y0.64%
Revenue Next 3Y1.91%
Revenue Next 5Y3.26%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
PHIA.AS Yearly Revenue VS EstimatesPHIA.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B 25B
PHIA.AS Yearly EPS VS EstimatesPHIA.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1 1.5 2

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 16.98 indicates a correct valuation of PHIA.
Based on the Price/Earnings ratio, PHIA is valued cheaper than 88.14% of the companies in the same industry.
When comparing the Price/Earnings ratio of PHIA to the average of the S&P500 Index (27.69), we can say PHIA is valued slightly cheaper.
Based on the Price/Forward Earnings ratio of 15.86, the valuation of PHIA can be described as correct.
Based on the Price/Forward Earnings ratio, PHIA is valued a bit cheaper than the industry average as 72.88% of the companies are valued more expensively.
PHIA's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.18.
Industry RankSector Rank
PE 16.98
Fwd PE 15.86
PHIA.AS Price Earnings VS Forward Price EarningsPHIA.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

PHIA's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. PHIA is cheaper than 71.19% of the companies in the same industry.
PHIA's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 54.25
EV/EBITDA 12.56
PHIA.AS Per share dataPHIA.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)40.91
PEG (5Y)N/A
EPS Next 2Y5.48%
EPS Next 3Y7.81%

0

5. Dividend

5.1 Amount

PHIA does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

KONINKLIJKE PHILIPS NV

AMS:PHIA (10/20/2025, 7:00:00 PM)

24.45

+0.19 (+0.78%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)11-04 2025-11-04
Inst Owners47.54%
Inst Owner ChangeN/A
Ins Owners0.06%
Ins Owner ChangeN/A
Market Cap23.54B
Analysts74.81
Price Target27.28 (11.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)-70.49%
DP0.62%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.64%
Min EPS beat(2)22.24%
Max EPS beat(2)31.04%
EPS beat(4)2
Avg EPS beat(4)6.19%
Min EPS beat(4)-16.56%
Max EPS beat(4)31.04%
EPS beat(8)3
Avg EPS beat(8)-1.09%
EPS beat(12)5
Avg EPS beat(12)15.29%
EPS beat(16)5
Avg EPS beat(16)3.51%
Revenue beat(2)0
Avg Revenue beat(2)-1.96%
Min Revenue beat(2)-1.97%
Max Revenue beat(2)-1.96%
Revenue beat(4)0
Avg Revenue beat(4)-3.05%
Min Revenue beat(4)-5.22%
Max Revenue beat(4)-1.96%
Revenue beat(8)0
Avg Revenue beat(8)-3.22%
Revenue beat(12)2
Avg Revenue beat(12)-1.61%
Revenue beat(16)2
Avg Revenue beat(16)-1.84%
PT rev (1m)-0.47%
PT rev (3m)4.09%
EPS NQ rev (1m)-0.38%
EPS NQ rev (3m)-3.82%
EPS NY rev (1m)-0.76%
EPS NY rev (3m)-8.66%
Revenue NQ rev (1m)-0.41%
Revenue NQ rev (3m)-3.44%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-2.94%
Valuation
Industry RankSector Rank
PE 16.98
Fwd PE 15.86
P/S 1.32
P/FCF 54.25
P/OCF 21.42
P/B 2.27
P/tB N/A
EV/EBITDA 12.56
EPS(TTM)1.44
EY5.89%
EPS(NY)1.54
Fwd EY6.3%
FCF(TTM)0.45
FCFY1.84%
OCF(TTM)1.14
OCFY4.67%
SpS18.54
BVpS10.78
TBVpS-1.76
PEG (NY)40.91
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.61%
ROE 1.56%
ROCE 5.69%
ROIC 4.27%
ROICexc 4.72%
ROICexgc 15.5%
OM 6.11%
PM (TTM) 0.91%
GM 43.85%
FCFM 2.43%
ROA(3y)-3.08%
ROA(5y)1.15%
ROE(3y)-7.29%
ROE(5y)2.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y10.6%
ROICexcg growth 5Y-2.51%
ROICexc growth 3Y4.73%
ROICexc growth 5Y-6.98%
OM growth 3Y-1.59%
OM growth 5Y-8.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.71%
GM growth 5Y1.08%
F-Score8
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.69
Debt/FCF 19.41
Debt/EBITDA 3.01
Cap/Depr 51.35%
Cap/Sales 3.72%
Interest Coverage 4
Cash Conversion 46.06%
Profit Quality 267.9%
Current Ratio 1.26
Quick Ratio 0.81
Altman-Z 1.94
F-Score8
WACC6.54%
ROIC/WACC0.65
Cap/Depr(3y)50.01%
Cap/Depr(5y)53.78%
Cap/Sales(3y)3.94%
Cap/Sales(5y)4.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)11.17%
EPS 3Y-5.66%
EPS 5Y-7.17%
EPS Q2Q%21.91%
EPS Next Y0.42%
EPS Next 2Y5.48%
EPS Next 3Y7.81%
EPS Next 5Y12.26%
Revenue 1Y (TTM)-1.53%
Revenue growth 3Y1.65%
Revenue growth 5Y1%
Sales Q2Q%-2.12%
Revenue Next Year-1.83%
Revenue Next 2Y0.64%
Revenue Next 3Y1.91%
Revenue Next 5Y3.26%
EBIT growth 1Y476.21%
EBIT growth 3Y0.03%
EBIT growth 5Y-7.17%
EBIT Next Year48.14%
EBIT Next 3Y21.01%
EBIT Next 5YN/A
FCF growth 1Y3516.67%
FCF growth 3Y-40.93%
FCF growth 5Y-1.73%
OCF growth 1Y43.47%
OCF growth 3Y-32.38%
OCF growth 5Y-4.03%